FAP and familial pancreatic carcinoma: Although upregulation of FAP is frequently associated with reduced OS and increased metastatic potential [84, 85], expression of FAP in specific tumor types, such as breast and pancreatic cancer, has been associated with improved DSF and OS [86, 87], consistent with our findings that FAP expression did not influence OS, but had a positive impact on DSF in EC patients.